Dolby Laboratories (NYSE:DLB) Hits New 1-Year Low on Insider Selling

Shares of Dolby Laboratories (NYSE:DLB) reached a new 52-week low on Tuesday following insider selling activity. The company traded as low as $53.20 and last traded at $53.5250, with a volume of 291085 shares trading hands. The stock had previously closed at $54.37.

Specifically, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $54.90, for a total value of $164,700.00. Following the completion of the transaction, the senior vice president owned 80,603 shares of the company’s stock, valued at approximately $4,425,104.70. This represents a 3.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Robert J. Park sold 4,895 shares of the company’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total transaction of $277,448.60. Following the completion of the transaction, the chief financial officer directly owned 81,490 shares of the company’s stock, valued at $4,618,853.20. This represents a 5.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on DLB shares. Rosenblatt Securities reaffirmed a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a report on Friday, January 30th. Barrington Research reaffirmed an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a report on Monday, April 27th. Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a report on Friday, March 27th. Finally, Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Dolby Laboratories has an average rating of “Moderate Buy” and a consensus target price of $90.75.

Dolby Laboratories Stock Performance

The firm’s fifty day simple moving average is $60.22 and its 200 day simple moving average is $63.42. The firm has a market cap of $5.11 billion, a P/E ratio of 21.36 and a beta of 0.86.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The business had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. During the same quarter in the prior year, the firm earned $1.34 EPS. The business’s revenue was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, equities research analysts predict that Dolby Laboratories will post 3.22 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.7%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 56.92%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in DLB. Royal Bank of Canada lifted its holdings in shares of Dolby Laboratories by 3.5% in the 1st quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock valued at $5,491,000 after acquiring an additional 2,298 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Dolby Laboratories by 218.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after acquiring an additional 171,288 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Dolby Laboratories by 5.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock valued at $19,131,000 after acquiring an additional 12,598 shares during the last quarter. Focus Partners Wealth bought a new position in shares of Dolby Laboratories in the 1st quarter valued at about $390,000. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Dolby Laboratories by 273.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock valued at $193,000 after acquiring an additional 1,902 shares during the last quarter. Institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.